Iterum Therapeutics plc (ITRMF) Revenue (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Revenue of $390000.0 for Q3 2025, up 954.05% quarter-over-quarter from $37000.0 in Q1 2019.
Iterum Therapeutics plc (ITRMF) Revenue (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $390000.0 for Q3 2025.
- In Q3 2025, Revenue changed N/A year-over-year to $390000.0; the TTM figure through Sep 2025 stood at $390000.0 (changed N/A YoY), while the FY2019 annual figure was $37000.0, down 95.74% from the prior year.
- Revenue for Q3 2025 stood at $390000.0, up from $37000.0 in the prior quarter.
- The five-year high for Revenue was $390000.0 in Q3 2025, with the low at $390000.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 390,000.00 |
| Mar 31, 2019 | 37,000.00 |
| Dec 31, 2018 | 239,000.00 |
| Sep 30, 2018 | 254,000.00 |
| Jun 30, 2018 | 185,000.00 |
| Mar 31, 2018 | 191,000.00 |
| Dec 31, 2017 | 349,000.00 |
| Sep 30, 2017 | 159,000.00 |